312 related articles for article (PubMed ID: 7536927)
1. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.
Ladbury JE; Lemmon MA; Zhou M; Green J; Botfield MC; Schlessinger J
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3199-203. PubMed ID: 7536927
[TBL] [Abstract][Full Text] [Related]
2. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
3. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
Bibbins KB; Boeuf H; Varmus HE
Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamic studies of tyrosyl-phosphopeptide binding to the SH2 domain of p56lck.
Lemmon MA; Ladbury JE
Biochemistry; 1994 May; 33(17):5070-6. PubMed ID: 7513553
[TBL] [Abstract][Full Text] [Related]
6. SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange.
Felder S; Zhou M; Hu P; Ureña J; Ullrich A; Chaudhuri M; White M; Shoelson SE; Schlessinger J
Mol Cell Biol; 1993 Mar; 13(3):1449-55. PubMed ID: 7680095
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance.
Payne G; Shoelson SE; Gish GD; Pawson T; Walsh CT
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4902-6. PubMed ID: 7685110
[TBL] [Abstract][Full Text] [Related]
8. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
9. Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor beta-receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach.
Panayotou G; Gish G; End P; Truong O; Gout I; Dhand R; Fry MJ; Hiles I; Pawson T; Waterfield MD
Mol Cell Biol; 1993 Jun; 13(6):3567-76. PubMed ID: 8388538
[TBL] [Abstract][Full Text] [Related]
10. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
Susa M; Rohner D; Bichsel S
Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
[TBL] [Abstract][Full Text] [Related]
12. Cooperative self-assembly of SH2 domain fragments restores phosphopeptide binding.
Williams KP; Shoelson SE
Biochemistry; 1993 Oct; 32(42):11279-84. PubMed ID: 7692962
[TBL] [Abstract][Full Text] [Related]
13. In vitro association of the phosphatidylinositol 3-kinase regulatory subunit (p85) with the human insulin receptor.
Ottinger EA; Hui TY; Man Z; Barany G; Bernlohr DA
Int J Pept Protein Res; 1995 Nov; 46(5):346-53. PubMed ID: 8567177
[TBL] [Abstract][Full Text] [Related]
14. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn.
Panchamoorthy G; Fukazawa T; Stolz L; Payne G; Reedquist K; Shoelson S; Songyang Z; Cantley L; Walsh C; Band H
Mol Cell Biol; 1994 Sep; 14(9):6372-85. PubMed ID: 7520528
[TBL] [Abstract][Full Text] [Related]
15. Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.
Marengere LE; Pawson T
J Biol Chem; 1992 Nov; 267(32):22779-86. PubMed ID: 1385407
[TBL] [Abstract][Full Text] [Related]
16. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
Case RD; Piccione E; Wolf G; Benett AM; Lechleider RJ; Neel BG; Shoelson SE
J Biol Chem; 1994 Apr; 269(14):10467-74. PubMed ID: 8144631
[TBL] [Abstract][Full Text] [Related]
17. Raf-1 interacts with Fyn and Src in a non-phosphotyrosine-dependent manner.
Cleghon V; Morrison DK
J Biol Chem; 1994 Jul; 269(26):17749-55. PubMed ID: 7517401
[TBL] [Abstract][Full Text] [Related]
18. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.
Domchek SM; Auger KR; Chatterjee S; Burke TR; Shoelson SE
Biochemistry; 1992 Oct; 31(41):9865-70. PubMed ID: 1382595
[TBL] [Abstract][Full Text] [Related]
20. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.
Nishimura R; Li W; Kashishian A; Mondino A; Zhou M; Cooper J; Schlessinger J
Mol Cell Biol; 1993 Nov; 13(11):6889-96. PubMed ID: 7692233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
